Skip to content
PICO Portalanswers from OpenAlex

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

PaperCitations, authors & open-access status

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China is a paper indexed in PICO Portal from OpenAlex.

How many citations does Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China have?

PICO Portalcitation count

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China has 5,043 citations in the OpenAlex counts PICO Portal stores.

When was Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China published?

PICO Portalyear

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China has 2020 year in the PICO Portal index.

What is the open-access status of Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China?

PICO Portaloa status

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China has bronze oa status in the PICO Portal index.

What is the DOI of Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China?

PICO Portaldoi

The DOI for Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China is on the source record.

What is the PMID of Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China?

PICO Portalpmid

The PMID for Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China is on the source record.

What is the OpenAlex record for Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China?

PICO Portalopenalex

The OpenAlex for Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial